Experts Warn Of Dangers In Australia's Mass H1N1 Flu Vaccination Plan
This article was originally published in PharmAsia News
Some Australian infectious-disease experts urged the government to cancel a plan to vaccinate as many people as possible against the H1N1 flu. They warned of a contamination risk that could spread blood-borne diseases. The Australasian Society for Infectious Disease sent a letter to the Health Ministry saying the risk lies in multi-dose vials for the vaccine supplied by CSL. The organization urged a delay in the mass-vaccination plan until the vaccine can be issued with single-dose vials. The letter said the medical community already knows multi-dose vials often transmit infectious diseases, some resulting in death. (Click here for more
You may also be interested in...
A round up of news from around the biopharma sector and its efforts to meet the challenges posed by the coronavirus pandemic.
The US FDA published on 29 March an emergency temporary guidance that relaxes oversight of certain sterilizers, disinfectant devices and air purifiers intended to kill the SARS-CoV-2 virus. See what the agency said about it here.
Purell Battling Class Actions Over Disease Claims While World Scrambles To Increase Hand Sanitizer Supplies
Leading chemical firms, beauty and consumer health companies, even distilleries and medical marijuana cultivators are adapting operations to meet global demand for hand sanitizers amid the COVID-19 pandemic. Meanwhile, plaintiff’s attorneys are busy with multiple class actions against Purell manufacturer GOJO Industries for alleged false advertising following a January warning letter to the firm from the US FDA.